A Phase 3, Non-Investıgatıonal Product, Multı Country Cohort Study To Descrıbe The Long-Term Safety And Effectıveness Of A Prıor Sıngle-Dose Treatment Wıth Investıgatıve Gıroctocogene Fıtelparvovec Or Fıdanacogene Elaparvovec In Partıcıpants Wıth Hemophılıa A Or Hemophılıa B, Respectıvely (C0371017)